PMC:7796052 / 3833-4023 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"132","span":{"begin":53,"end":55},"obj":"Gene"},{"id":"139","span":{"begin":127,"end":135},"obj":"Disease"}],"attributes":[{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"Gene:3827"},{"id":"A139","pred":"tao:has_database_id","subj":"139","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In other to swiftly test the efficacy of alternative BK antagonists with diverse pharmacological profiles for the treatment of Covid-19, drug repurposing represents a valuable strategy [22]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":0,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In other to swiftly test the efficacy of alternative BK antagonists with diverse pharmacological profiles for the treatment of Covid-19, drug repurposing represents a valuable strategy [22]."}